ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
TransCode Therapeutics Inc

TransCode Therapeutics Inc (RNAZ)

7.21
-0.68
(-8.62%)
Closed December 12 3:00PM
7.21
0.00
( 0.00% )
Pre Market: 6:03AM

TransCode Therapeutics Inc Financial Summary

The current RNAZ market cap is 5.02M. The company's latest EPS is USD -26.6376 and P/E is -0.27.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -5.33M-4.06M-3.29M-5.11M-2.17M
Net Income -5.3M-4.09M-3.33M-5.19M-2.32M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -457k-726k-6.15M-18.67M-19.42M
Net Income -607k-2.34M-6.84M-17.57M-18.55M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 10.23M5.17M7.29M4.83M3.94M
Total Liabilities 5.79M3.53M2.71M3.5M2.28M
Total Equity 4.44M1.64M4.58M1.32M1.65M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 204k1.06M22.94M7.59M5.17M
Total Liabilities 1.31M4.46M2.53M4.35M3.53M
Total Equity -1.11M-3.41M20.4M3.24M1.64M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -12.41M-18.07M-3.94M-6.28M-10.19M
Investing -35k-36k-4k-8k-21k
Financing 14.93M15.91M6.09M6.87M9.32M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -509k-493k-5.27M-15.76M-18.07M
Investing N/A N/A -252k-101k-36k
Financing 500k1.12M25.52M5k15.91M
Market Cap 5.02M
Price to Earnings Ratio -0.27
Price to Sales Ratio 0
Price to Cash Ratio 1.81
Price to Book Ratio 3.06
Dividend Yield -

Share Statistics

Shares Outstanding 696.23k
Average Volume (1 week) 30.48k
Average Volume (1 Month) 432.34k
52 Week Change -96.59%
52 Week High 264.00
52 Week Low 6.6332
Spread (Intraday) 1.62 (20%)

Company Info

Company Name TransCode Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.transcodetherapeutics.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock